Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Optical Breast Imaging Developers Seek Light At The End Of The Tunnel

This article was originally published in The Gray Sheet

Executive Summary

The challenges of developing a next-generation breast cancer screening technology that targets tumor vessels has already overwhelmed one company, but others continue to persevere to reach FDA's finish-line

You may also be interested in...



Imaging Is Key To Product Development In Critical Path Opportunities List

Imaging techniques hold "vast potential" to help speed the development of new medical products, FDA says in the latest report on its Critical Path initiative

Dobi Anticipates FDA Approval For Long-Delayed ComfortScan In 2007

Dobi Medical International hopes to submit final clinical data for its ComfortScan PMA by the end of 2006 with the goal of launching the long-delayed imaging system as an adjunct to mammography in 2007

Digital Mammography More Accurate Than Film For Younger Women – NEJM

Digital mammography is more accurate than traditional film mammography in women under 50 and women with dense breasts, according to a study slated to appear in the Oct. 27 New England Journal of Medicine

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT023828

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel